Federal Trade Commission February 25, 2016 – Federal Register Recent Federal Regulation Documents

Results 1 - 2 of 2

Lupin Ltd., Gavis Pharmaceuticals LLC, and Novel Laboratories, Inc.; Analysis To Aid Public Comment

Document Number: 2016-04040

Type: Notice

Date: 2016-02-25

Agency: Federal Trade Commission, Agencies and Commissions

The consent agreement in this matter settles alleged violations of federal law prohibiting unfair methods of competition. The attached Analysis to Aid Public Comment describes both the allegations in the draft complaint and the terms of the consent ordersembodied in the consent agreementthat would settle these allegations.

https://regulations.justia.com/regulations/fedreg/2016/02/25/2016-04040.html

Hikma Pharmaceuticals PLC and C.H. Boehringer Sohn AG & Co. KG; Analysis To Aid Public Comment

Document Number: 2016-04039

Type: Notice

Date: 2016-02-25

Agency: Federal Trade Commission, Agencies and Commissions

The consent agreement in this matter settles alleged violations of federal law prohibiting unfair methods of competition. The attached Analysis to Aid Public Comment describes both the allegations in the draft complaint and the terms of the consent order embodied in the consent agreementthat would settle these allegations.

https://regulations.justia.com/regulations/fedreg/2016/02/25/2016-04039.html